Vivani Medical Inc (VANI) Stock Price, Quote & News

Company Profile

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease and medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in clinical stage development for the treatment of chronic weight management i...

Industry: Biotechnology

Sector: Healthcare

Phone: 415 506 8462

Website: www.vivani.com

Address:

1350 South Loop Road, Alameda, United States

OfficialStocktwitsUser Feb. 19 at 10:21 PM

$VANI RSI: 36.00, MACD: -0.0289 Vol: 0.11, MA20: 1.34, MA50: 1.34 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

BillionerOfKing Feb. 18 at 7:12 PM

$VANI Current Stock Price: $1.32 Contracts to trade: $1.0 VANI Feb 20 2026 Call Entry: $0.23 Exit: $0.42 ROI: 79% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

LogicalTrading Feb. 17 at 3:09 PM

$VANI insider activity adding — $ALT added more to this too on dip — ALT pt of $7 👀

0 · Reply

AZOZ Feb. 17 at 12:50 PM

$VANI Insider activity!

0 · Reply

BC322032 Feb. 12 at 9:26 PM

$VANI

0 · Reply

Repunza Feb. 11 at 4:57 PM

$VANI lol good ole vani doing what it do best. Red red pee the

0 · Reply

A_MR_E Feb. 11 at 4:31 PM

$VANI What a crap show... Do something with your marketing already.

0 · Reply

wolfcyd3 Feb. 11 at 3:31 PM

$VANI

0 · Reply

TradeNerve Feb. 10 at 1:11 PM

$VANI is a vanity or consumer brand; requires constant marketing to maintain relevance.

0 · Reply

MXtraderUS Feb. 6 at 7:43 PM

$VANI here is a more recent update on an implant to help blind people able to see. As well loads of insider buying. The article states that the result were all positive. It was done on a 6 year study. https://finance.yahoo.com/news/vivani-subsidiary-cortigent-presents-promising-123000540.html

1 · Reply

Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026

Jan 27, 2026, 4:05 PM EST - 4 weeks ago

Vivani Medical, Inc. Announces Closing of Common Stock Offering

Jan 25, 2026, 11:36 PM EST - 4 weeks ago

Vivani Medical, Inc. Announces Pricing of Common Stock Offering

Nov 13, 2025, 7:45 AM EST - 3 months ago

Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results

Oct 3, 2025, 8:30 AM EDT - 5 months ago

Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off

Sep 24, 2025, 9:15 AM EDT - 5 months ago

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2025

Sep 17, 2025, 8:30 AM EDT - 5 months ago

Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders

Sep 4, 2025, 8:30 AM EDT - 6 months ago

Vivani Medical Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight Management

Aug 20, 2025, 8:30 AM EDT - 6 months ago

Vivani Medical CEO Adam Mendelsohn to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025

Aug 13, 2025, 4:20 PM EDT - 7 months ago

Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results

May 20, 2025, 5:47 AM EDT - 10 months ago

I Missed The Quantum Rally - I Won't Miss The Next One

AMSC AUTL CAPR CLPT EDIT NTLA VERV

May 13, 2025, 4:30 PM EDT - 10 months ago

Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results

May 7, 2025, 8:30 AM EDT - 10 months ago

Vivani Medical to Present at the American Association of Pharmaceutical Scientists' “Beyond GLP1s: Where the Science will Take Business Next” Virtual Workshop

Apr 15, 2025, 8:30 AM EDT - 11 months ago

Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity

Mar 31, 2025, 7:30 AM EDT - 11 months ago

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 27, 2025, 7:32 AM EDT - 1 year ago

Vivani Medical Announces $8.25M Private Placement Equity Financing

Mar 26, 2025, 7:30 AM EDT - 1 year ago

Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing

Mar 24, 2025, 8:30 AM EDT - 1 year ago

Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025

Mar 13, 2025, 7:30 AM EDT - 1 year ago

Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults

Mar 12, 2025, 8:30 AM EDT - 1 year ago

Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business

Mar 12, 2025, 8:00 AM EDT - 1 year ago

EXCLUSIVE: Vivani Medical To Spin Off Cortigent Neurostimulation Business To Create Better Focus On Individual Entities And Shareholder Value

CRGT

Dec 19, 2024, 8:30 AM EST - 1 year ago

Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Dec 4, 2024, 8:30 AM EST - 1 year ago

Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast

Nov 13, 2024, 8:30 AM EST - 1 year ago

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results

Oct 22, 2024, 8:30 AM EDT - 1 year ago

Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024

Sep 26, 2024, 8:30 AM EDT - 1 year ago

Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Sep 23, 2024, 8:57 AM EDT - 1 year ago

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024

Sep 4, 2024, 8:00 AM EDT - 1 year ago

Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant

Aug 28, 2024, 7:10 PM EDT - 1 year ago

Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Aug 13, 2024, 4:05 PM EDT - 1 year ago

Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results

Jul 11, 2024, 8:00 AM EDT - 1 year ago

Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115

Jun 13, 2024, 8:00 AM EDT - 1 year ago

Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant

May 28, 2024, 8:00 AM EDT - 1 year ago

Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant

May 13, 2024, 4:45 PM EDT - 1 year ago

Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results

May 9, 2024, 8:00 AM EDT - 1 year ago

Vivani Medical to Present at TIDES Conference 2024

Mar 26, 2024, 8:30 AM EDT - 2 years ago

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 6, 2024, 8:00 AM EST - 2 years ago

Vivani Medical Appoints Daniel Bradbury to its Board of Directors

Mar 1, 2024, 7:49 AM EST - 2 years ago

Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants

Feb 29, 2024, 7:25 AM EST - 2 years ago

Vivani Medical (VANI) stock price surged: is it a good buy?

Feb 28, 2024, 8:30 AM EST - 2 years ago

Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio

Nov 14, 2023, 6:00 AM EST - 2 years ago

Vivani Medical Provides Business Update and Reports Third Quarter Financial Results

Oct 16, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical to Present at BIO Investor Forum

Sep 7, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical to Present at the Boulder Peptide Symposium

Sep 5, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical Subsidiary Cortigent to Present Orion Clinical Study Results at The Eye and The Chip World Research Congress on Artificial Vision October 8-10

Aug 14, 2023, 5:45 PM EDT - 2 years ago

Vivani Medical Reports Second Quarter Financial Results and Provides Business Update

Jul 11, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical, Inc. Subsidiary Cortigent Reports 5-Year Early Feasibility Study Update for the Orion® Visual Cortical Prosthesis System

Jun 14, 2023, 6:00 AM EDT - 2 years ago

Vivani Medical to Participate in Panel Discussion at the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest

May 15, 2023, 6:15 AM EDT - 3 years ago

Vivani Medical Reports First Quarter Financial Results and Provides Business Update

Apr 4, 2023, 6:00 AM EDT - 3 years ago

Vivani Medical Announces $1 Million NIH Grant Funding to Support Cortigent's Ongoing Orion Clinical Study

Mar 31, 2023, 2:50 PM EDT - 3 years ago

Vivani Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

OfficialStocktwitsUser Feb. 19 at 10:21 PM

0 · Reply

BillionerOfKing Feb. 18 at 7:12 PM

0 · Reply

LogicalTrading Feb. 17 at 3:09 PM

$VANI insider activity adding — $ALT added more to this too on dip — ALT pt of $7 👀

0 · Reply

AZOZ Feb. 17 at 12:50 PM

$VANI Insider activity!

0 · Reply

BC322032 Feb. 12 at 9:26 PM

$VANI

0 · Reply

Repunza Feb. 11 at 4:57 PM

$VANI lol good ole vani doing what it do best. Red red pee the

0 · Reply

A_MR_E Feb. 11 at 4:31 PM

$VANI What a crap show... Do something with your marketing already.

0 · Reply

wolfcyd3 Feb. 11 at 3:31 PM

$VANI

0 · Reply

TradeNerve Feb. 10 at 1:11 PM

$VANI is a vanity or consumer brand; requires constant marketing to maintain relevance.

0 · Reply

MXtraderUS Feb. 6 at 7:43 PM

1 · Reply

Chemaster Feb. 6 at 5:01 PM

$VANI Can someone post a clinical Phase progress and summary. Why do you like this stock? Just looking into it ..

0 · Reply

MXtraderUS Feb. 5 at 9:22 PM

$VANI 4 hr, daily, weekly and monthly charts showing a gap fill to the $1.40 range. It can reach it with volume. Might take a little time but if the market sentiment returns back to green it could get it rolling. Not a bad swing play. Got a small starter position to see what it can bring.

0 · Reply

1SwingSensei Feb. 4 at 5:02 PM

$VANI Finally filled the gap, let's see if we close green & how long it'll take to get above $1.80

0 · Reply

wolfcyd3 Feb. 4 at 3:56 PM

$VANI will we ever see an actual open market buy here from an insider or will they all be buys via dilution? That is why there is never any momentum here

1 · Reply

Kkai14 Feb. 4 at 3:01 PM

$VANI

0 · Reply

Tfizzle Feb. 3 at 8:27 PM

$VANI adding more if dips from this range

0 · Reply

rombrento Feb. 3 at 5:56 AM

$VANI

0 · Reply

Tfizzle Feb. 3 at 12:06 AM

$VANI setting up similar to $MAIA in december

0 · Reply

OfficialStocktwitsUser Feb. 2 at 8:14 PM

$VANI RSI: 61.90, MACD: 0.0306 Vol: 0.09, MA20: 1.36, MA50: 1.36 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

ENKU Feb. 2 at 4:23 PM

$VANI

0 · Reply

Nataina Feb. 2 at 5:31 AM

$VANI

0 · Reply

Nataina Feb. 2 at 5:30 AM

$VANI up 7 percent now

0 · Reply

Market Cap	99.27M
Revenue (ttm)	0.00
Net Income (ttm)	-23.49M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	108,811
Avg Vol	344,170
Day's Range	N/A - N/A
Shares Out	78.17M
Stochastic %K	61%
Beta	3.11
Analysts	Strong Sell
Price Target	$4.00